Company information:

UCB Bulgaria is integral part of UCB group of companies: global biopharmaceutical company with 90 years of history and focused on creating value for people living with
severe diseases in immunology and neurology now and into the future. We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives, while creating value for society. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients
in need.
UCB’s business is strong and ranked 3rd among top Belgium companies by market capitalization as on Jan 1st, 2021##. Total revenue grew to €5.3 billion in 2020. We are
more than 7,600 people in all four corners of the globe, inspired by patients and driven by science.


Company details

Year of establishment: 2001
Number of employees: 8
Key investments since establishment in Bulgaria: >1 million Bulgarian patients’ lives covered with UCB solutions since its presence in the country; >65 thousand annualized monthly average treated patients in 2020; ~1€ million local R&D and >0.75€ million investments in healthcare professionals & patient organizations’ education and support for the 2017-2019 period; UCB products for >12.5€ million released on the local market in 2020
Phone: +359 (2) 962 30 49
Email: Office.Bulgaria@ucb.com
Address: Sofia 1407, 2B Srebarna Street, Floor 9, Office 8B

Share this page